Pathology of Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Gynecologic Cancer ◽

10.1016/b978-0-443-07142-3.50031-2 ◽

2004 ◽

pp. 369-386

Author(s):

Melissa J. Robbie

Keyword(s):

Fallopian Tube ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Improved Optimal Cytoreduction Rates for Stages IIIC and IV Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer: A Change in Surgical Approach

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70606-4 ◽

2006 ◽

Vol 2006 ◽

pp. 466-467

Author(s):

G. Rodriguez

Keyword(s):

Fallopian Tube ◽

Surgical Approach ◽

Optimal Cytoreduction ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

PREDICTING OUTCOME IN EPITHELIAL OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER ACCORDING TO HISTOLOGICAL TUMOUR RESPONSE TO NEO-ADJUVANT CHEMOTHERAPY, AT THE TIME OF INTERVAL DEBULKING.

10.26226/morressier.5770e29cd462b80290b4c049 ◽

2016 ◽

Author(s):

Sinead Barry

Keyword(s):

Adjuvant Chemotherapy ◽

Fallopian Tube ◽

Tumour Response ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Predicting Outcome ◽

Neo Adjuvant Chemotherapy

Download Full-text

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Case Medical Research ◽

10.31525/ct1-nct03907527 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Fallopian Tube ◽

Immune Cells ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Car T Cells ◽

Platinum Resistant ◽

Download Full-text

Clinical Activity of Gemcitabine Plus Pertuzumab in Platinum-Resistant Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Yearbook of Oncology ◽

10.1016/j.yonc.2011.07.017 ◽

2011 ◽

Vol 2011 ◽

pp. 78-79

Author(s):

J.T. Thigpen

Keyword(s):

Ovarian Cancer ◽

Fallopian Tube ◽

Clinical Activity ◽

Fallopian Tube Cancer ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Resistant

Download Full-text

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for assessing tumour resectability in advanced epithelial ovarian, fallopian tube and/or primary peritoneal cancer

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012567 ◽

2017 ◽

Author(s):

Jacob P Hoogendam ◽

Joline F Roze ◽

Fleur T van de Wetering ◽

René Spijker ◽

Leen Verleye ◽

...

Keyword(s):

Magnetic Resonance Imaging ◽

Positron Emission Tomography ◽

Magnetic Resonance ◽

Fallopian Tube ◽

Emission Tomography ◽

Resonance Imaging ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Positron Emission ◽

Magnetic Resonance Imaging Mri

Download Full-text

CYTOREDUCTIVE SURGERY (CRS) AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) IN PATIENTS WITH ADVANCED OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER: OUR EXPERIENCE IN 108 PATIENTS

10.26226/morressier.5d2ee8eb1e09a6f49485abf9 ◽

2019 ◽

Author(s):

Mihai Emil Capilna ◽

MIHAI GHEORGHE ◽

Szilard Leo Kiss ◽

Alexandra Lavinia Cozlea

Keyword(s):

Fallopian Tube ◽

Intraperitoneal Chemotherapy ◽

Cytoreductive Surgery ◽

Hyperthermic Intraperitoneal Chemotherapy ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The Lancet Oncology ◽

10.1016/s1470-2045(13)70363-2 ◽

2013 ◽

Vol 14 (10) ◽

pp. 1020-1026 ◽

Author(s):

Noriyuki Katsumata ◽

Makoto Yasuda ◽

Seiji Isonishi ◽

Fumiaki Takahashi ◽

Hirofumi Michimae ◽

...

Keyword(s):

Fallopian Tube ◽

Long Term Results ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Open Label Trial ◽

Randomised Controlled

Download Full-text

Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

American Journal of Clinical Oncology ◽

10.1097/coc.0000000000000413 ◽

2018 ◽

Vol 41 (10) ◽

pp. 938-942 ◽

Author(s):

Vaagn Andikyan ◽

Annie Kim ◽

Herbert F. Gretz ◽

Konstantin Zakashansky ◽

Monica Prasad-Hayes ◽

...

Keyword(s):

Fallopian Tube ◽

Optimal Cytoreduction ◽

Debulking Surgery ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Primary Debulking Surgery

Download Full-text

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach

The Women s Oncology Review ◽

10.3109/14733400500034324 ◽

2004 ◽

Vol 4 (4) ◽

pp. 263-264

Keyword(s):

Fallopian Tube ◽

Surgical Approach ◽

Optimal Cytoreduction ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Abstract CT091: Phase I study of intraperitoneal TRX-E-002-1 in patients with persistent or recurrent ovarian cancer, fallopian tube cancer or primary peritoneal cancer: Results of dose-escalation phase

10.1158/1538-7445.am2019-ct091 ◽

2019 ◽

Author(s):

Jermaine Coward ◽

Don Dizon ◽

Ganessan Kichenadasse ◽

Paul Harnett ◽

Kathleen Moore ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase I ◽

Fallopian Tube ◽

Dose Escalation ◽

Phase I Study ◽

Recurrent Ovarian Cancer ◽

Fallopian Tube Cancer ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text